Mubadala Investment Co PJSC - 20 Nov 2024 SCHEDULE 13D/A Report for RECURSION PHARMACEUTICALS, INC. Class A Common Stock, $0.00001 par value per share (RXRX)

Filing Manager: Mubadala Investment Co PJSC
Reporting Manager: Mubadala Investment Co PJSC
Security: RECURSION PHARMACEUTICALS, INC. Class A Common Stock, $0.00001 par value per share
Symbol: RXRX
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13D/A
Filing time: 23 Dec 2025, 19:25:11 UTC
Date of event: 20 Nov 2024
SEC: View on sec.gov

Reporting Managers (7)

Name	Ownership	Shares Owned	shared voting power	Signature	Title	CIK
Mubadala Investment Co PJSC	0%	0	0	/s/ Samer Halawa	Samer Halawa, Chief Legal Officer	0001704268
Mamoura Diversified Global Holding PJSC	0%	0	0	/s/ Samer Halawa	Samer Halawa, Chief Legal Officer	0001419351
MDC Capital Partners (Ventures) GP, LP	1.4%	7,062,869	7,062,869	/s/ Rodney Cannon	Rodney Cannon, Manager
MDC Capital Partners (Ventures), LP	1.4%	7,062,869	7,062,869	/s/ Rodney Cannon	Rodney Cannon, Manager	0001714230
MIC Capital Management UK LLP	0.5%	2,581,164	2,581,164	/s/ Rodney Cannon	Rodney Cannon, General Counsel	0001889830
MC Alternative Solutions, LP	0.3%	1,388,889	1,388,889	/s/ Rodney Cannon	Rodney Cannon, Manager	0001974767
MIC Capital Partners (Ventures) Europe Parallel (Luxembourg) Aggregator SCSp	0.2%	1,192,275	1,192,275	/s/ Rodney Cannon	Rodney Cannon, Manager